Floreliz Mendoza
National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Mosquito-borne diseases and control, Malaria Research and Control, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, Influenza Virus Research Studies
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
- → A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited
- → Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial(2014)248 cited
- → Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited
- → Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study(2019)125 cited
- → Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria(2022)115 cited
- → Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial(2019)105 cited